{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-236156","form_type":"8-K","ticker":null,"cik":"0001796129","company_name":"Vincerx Pharma, Inc.","filed_at":"2023-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.275771+00:00","generated_at":"2026-06-10T16:31:54.146683+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vincerx Pharma receives Nasdaq bid price deficiency notice","bullets":["Closing bid price below $1.00 for 30 consecutive business days triggers Nasdaq notice.","Company has 180 calendar days to regain compliance by closing at $1.00+ for 10 consecutive days.","If not cured, Company may be eligible for an additional 180-day compliance period.","Reverse stock split is among options being considered to remedy the deficiency.","Failure to regain compliance could result in delisting from Nasdaq Capital Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-236156","json":"https://secwatch.observer/filing/0001193125-23-236156.json","markdown":"https://secwatch.observer/filing/0001193125-23-236156.md","text":"https://secwatch.observer/filing/0001193125-23-236156.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796129/000119312523236156/0001193125-23-236156-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796129/000119312523236156/d521234d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T16:31:54.146683+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ed646c4be037411274872910157eb8fdafbcecbb","claim":"Vincerx Pharma, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"September 14, 2023, Vincerx Pharma, Inc. (“Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of the Company’s common stock for the last 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share. The Notice has no immediate effect on the listing or trading of the Company’s common stock, which continues to trade on The Nasdaq Capital Market under the symbol “VINC.” In accordance with Nasdaq Listing R","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1796129/000119312523236156/0001193125-23-236156-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}